BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 25556579)

  • 1. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.
    Chang X; Liu T; Zhang F; Ji C; Zhao X; Wang W; Guo H
    J Endourol; 2015 May; 29(5):518-25. PubMed ID: 25556579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome.
    Park BK; Gong IH; Kang MY; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
    Eur Radiol; 2018 Jul; 28(7):2979-2985. PubMed ID: 29426988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: long-term clinical and oncologic outcomes.
    Chang X; Zhang F; Liu T; Ji C; Zhao X; Yang R; Yan X; Wang W; Guo H
    J Urol; 2015 Feb; 193(2):430-5. PubMed ID: 25106899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
    Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
    Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
    Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes.
    Chlorogiannis DD; Kratiras Z; Efthymiou E; Moulavasilis N; Kelekis N; Chrisofos M; Stravodimos K; Filippiadis DK
    Cardiovasc Intervent Radiol; 2024 May; 47(5):573-582. PubMed ID: 38561521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors for Long-Term Survival in Patients with Renal-Cell Carcinoma After Radiofrequency Ablation.
    Zhang F; Chang X; Liu T; Wang W; Zhao X; Ji C; Yang R; Guo H
    J Endourol; 2016 Jan; 30(1):37-42. PubMed ID: 26222920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma.
    Takaki H; Soga N; Kanda H; Nakatsuka A; Uraki J; Fujimori M; Yamanaka T; Hasegawa T; Arima K; Sugimura Y; Sakuma H; Yamakado K
    Radiology; 2014 Jan; 270(1):292-9. PubMed ID: 23925272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological and Functional Outcomes of Laparoscopic Radiofrequency Ablation and Partial Nephrectomy for T1a Renal Masses: A Retrospective Single-center 60 Month Follow-up Cohort Study.
    Park JM; Yang SW; Shin JH; Na YG; Song KH; Lim JS
    Urol J; 2019 Feb; 16(1):44-49. PubMed ID: 30120758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
    Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
    Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
    Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
    BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
    Ma Y; Bedir S; Cadeddu JA; Gahan JC
    BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.